CHA News Article

CHA Urges HRSA to Make 340B Program Final Rule Effective Jan. 1
Final rule addresses ceiling prices, civil monetary penalties

CHA has prepared the attached comment letter urging the Health Resources and Services Administration (HRSA) to make its final rule addressing ceiling prices for drugs purchased under the 340B Drug Pricing Program effective on Jan. 1, 2019.

CHA encourages members to use the letter to submit their own comments, which are due Nov. 23.

In its letter, CHA underscores the program’s importance to the 181 California hospitals that rely on it to stretch scarce resources. CHA also notes that “Promptly implementing the final rule on 340B drug ceiling prices and [civil monetary penalties] is a crucial step in addressing the rising costs of prescription drugs.”